This fund focuses on the biotechnology sector by investing at least 80% of its assets in stocks that make up the S&P Biotechnology Select Industry Index. Rather than buying every stock in the index, it uses a selective approach to closely mirror the index's overall performance. The index itself is drawn from the broader S&P Total Market Index and covers companies operating in the biotechnology industry.
